is compounded tirzepatide fda approved confirms shortage still over, gives compounders a grace period Compounded Tirzepatide: Legal & Safe

Evening injection also offers a social advantage that morning dosing does not

This provides a convenient, needle-free alternative for people who want help with weight loss

Presented Jan 10, 2026

Canadian Market Context The Canadian market presents unique considerations for those interested in these weight loss compounds

21 Bariatric surgery In a retrospective analysis of 2,695 patients who underwent bariatric surgery, 1.04% of patients (versus 0.017% of the general population) developed acute pancreatitis during a median follow-up of 3.5 years (interquartile range 1.95.8 years)

More study results are expected in 2026, and it could potentially be approved as early as 2027